Catechol-O-methyltransferase genotype modulates opioid release in decision circuitry
Jennifer M Mitchell1, James P O'Neil, William J Jagust
1Ernest Gallo Clinic & Research Center, University of California San Francisco, Emeryville, California, USA; Department of Neurology, University of California San Francisco, San Francisco, California, USA.
Abstract:
Impulsivity, a risk factor for substance abuse disorders, is modulated by the Val158 variant of the catechol-O-methyltransferase (COMT) gene. Rodent studies have shown that opioids enhance impulsivity. Furthermore, alcohol consumption leads to endogenous opioid release in the cortex and nucleus accumbens (NAc), and this opioid release is correlated with greater positive hedonic effect. Using the selective mu opioid receptor radioligand [¹¹C] carfentanil, we find that, following alcohol consumption, individuals with the COMT Val158 allele have greater opioid release in the right NAc but less release in medial orbital frontal cortex (OFC). These data suggest that genetic regulation of dopamine levels can affect alcohol consumption in part by modulating endogenous opioid release in specific brain regions implicated in reward, which in turn promotes impulsive choice.
Related Concept Videos
Opioid Receptors: Overview
Drugs Affecting Neurotransmitter Synthesis
Neurochemical Transmission: Sites of Drug Action
Drugs Affecting Neurotransmitter Release or Uptake
Drug Abuse and Addiction: Pharmacological Phenomena
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...


